Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 9, 2015
- Accepted in final form June 15, 2015
- First Published August 13, 2015.
Author Disclosures
- Xia Tian, PhD*,
- Wen-Chen Liang, MD*,
- Yanming Feng, PhD*,
- Jing Wang, MD,
- Victor Wei Zhang, PhD,
- Chih-Hung Chou, MS,
- Hsien-Da Huang, PhD,
- Ching Wan Lam, PhD,
- Ya-Yun Hsu, PhD,
- Thy-Sheng Lin, MD,
- Wan-Tzu Chen, MS,
- Lee-Jun Wong, PhD and
- Yuh-Jyh Jong, MD
- Xia Tian, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
Baylor Miraca Genetic Laboratories, Research Associate, 4 months Baylor Miraca Genetic Laboratories that offer fee-for-service NGS based molecular testing for neuromuscular disorders.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wen-Chen Liang, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yanming Feng, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jing Wang, MD,
NONE
NONE
NONE
NONE
NONE
NONE
Baylor Miraca Genetics Laboratories, director,9 years
NONE
NONE
NONE
NONE
Commercial entity
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Victor Wei Zhang, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chih-Hung Chou, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hsien-Da Huang, PhD,
NONE
NONE
NONE
(1) BMC Bioinformatics, Editorial board, 2009-present. (2) MicroRNA, Editorial board, 2010-present. (3) Genomics, Proteomics & Bioinformatics, Editorial board, 2010-present. (4) Journal of Neuroscience and Neuroengineering, Editorial board, 2012- present.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NSC 101—2311-B-009—005-MY3 NSC 102—2627-B-009—001
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ching Wan Lam, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ya-Yun Hsu, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thy-Sheng Lin, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wan-Tzu Chen, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lee-Jun Wong, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yuh-Jyh Jong, MD
1) Non-profit entity: Asian Oceanian Myology Center
NONE
NONE
Pediatrics and Neonatology, Editor-in-Chief, 2011-05 - 2014- 05; Consulting Editor, 2014-5 - present.
1.)Li H, Hsieh-Li HM, Chang JG, Jong YJ. Knockout-transgenic mouse model of spinal muscular atrophy. US 6,245,963,2001. 2.)Chang JG, Jong YJ, Tsa FJ. Hydroxyurea treatment for spinal muscular atrophy. US 6,573,300, 2003. 3.)Wu SM, Wang CC, Chang JG, Jong YJ. Methods for diagnosing spinal muscular atrophy . Taiwan I350312, 2011. 4.)Wu SM, Wang CC, Chang JG, Jong YJ. Method for diagnosing spinal muscular atrophy. US 7,875,432,2011. 5.)Wu SM, Wang CC, Chang JG, Jong YJ. Method for diagnosing spinal muscular atrophy. US 8,067,568,2011. 6.)Wu SM, Wang CC, Chang JG, Jong YJ. Method for diagnosing spinal muscular atrophy. Israel?210023. 7.)Chang YF. Liu TY, Jong YJ, Chang JG.. hnRNP A1 knockout animal model and use thereof. US:8,946,503 B2.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Baylor Miraca Genetics Laboratories (X.T., Y.F., J.W., V.W.Z., L.-J.W.), Houston, TX; Department of Pediatrics (W.-C.L., Y.-J.J.), Department of Laboratory Medicine (Y.-J.J.), and Department of Pathology (W.-T.C.), Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine (Y.-J.J.), College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Molecular and Human Genetics (J.W., V.W.Z., L.-J.W.), Baylor College of Medicine, Houston, TX; Institute of Bioinformatics and Systems Biology (C.-H.C., H.-D.H.), and Department of Biological Science and Technology (H.-D.H., Y.-J.J.), National Chiao Tung University, Hsinchu, Taiwan; Department of Pathology (C.W.L.), The University of Hong Kong, Pokfulam, Hong Kong; and Department of Neurology (T.-S.L.), National Cheng Kung University Medical College and Hospital, Tainan, Taiwan.
- Correspondence to Dr. Wong: ljwong{at}bcm.edu or Dr. Jong: yjjong{at}gap.kmu.edu.tw
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathyOzge Ceyhan-Birsoy, Pankaj B. Agrawal, Carlos Hidalgo et al.Neurology, August 23, 2013 -
Article
Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in DenmarkNanna Witting, Ulla Werlauff, Morten Duno et al.Neurology: Genetics, March 21, 2017 -
Editorial
Next-generation sequencing still needs our generation's cliniciansA. Reghan Foley, Sandra Donkervoort, Carsten G. Bönnemann et al.Neurology Genetics, August 13, 2015 -
Articles
Early-onset parkinsonism associated with PINK1 mutationsFrequency, genotypes, and phenotypesV. Bonifati, C. F. Rohé, G. J. Breedveld et al.Neurology, July 11, 2005